###begin article-title 0
Protective and Enhancing HLA Alleles, HLA-DRB1*0901 and HLA-A*24, for Severe Forms of Dengue Virus Infection, Dengue Hemorrhagic Fever and Dengue Shock Syndrome
###end article-title 0
###begin p 1
Conceived and designed the experiments: NTPL MK VTQH DQH TTT VDT HMT TVD KM MY KH. Performed the experiments: NTPL MK VTQH MY KH. Analyzed the data: NTPL MK VTQH MY KH. Contributed reagents/materials/analysis tools: NTPL MK VTQH DQH TTT VDT HMT VVT CTPN TVD TO KM MY KH. Wrote the paper: NTPL MK VTQH KM MY KH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 12 <span type="species:ncbi:12637">Dengue virus</span>
###xml 14 16 <span type="species:ncbi:12637">DV</span>
###xml 234 242 <span type="species:ncbi:9606">children</span>
Dengue virus (DV) infection is one of the most important mosquito-borne diseases in the tropics. Recently, the severe forms, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), have become the leading cause of death among children in Southern Vietnam. Protective and/or pathogenic T cell immunity is supposed to be important in the pathogenesis of DHF and DSS.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 60 72 <span type="species:ncbi:12637">dengue virus</span>
###xml 74 76 <span type="species:ncbi:12637">DV</span>
###xml 131 139 <span type="species:ncbi:9606">Children</span>
###xml 281 289 <span type="species:ncbi:9606">patients</span>
###xml 486 494 <span type="species:ncbi:9606">children</span>
###xml 687 695 <span type="species:ncbi:9606">patients</span>
###xml 867 875 <span type="species:ncbi:9606">patients</span>
To identify HLA alleles controlling T cell immunity against dengue virus (DV), we performed a hospital-based case control study at Children's Hospital No.2, Ho Chi Minh City (HCMC), and Vinh Long Province Hospital (VL) in Southern Vietnam from 2002 to 2005. A total of 211 and 418 patients with DHF and DSS, respectively, diagnosed according to the World Health Organization (WHO) criteria, were analyzed for their characteristic HLA-A, -B and -DRB1 alleles. Four hundred fifty healthy children (250 from HCMC and 200 from VL) of the same Kinh ethnicity were also analyzed as population background. In HLA class I, frequency of the HLA-A*24 showed increased tendency in both DHF and DSS patients, which reproduced a previous study. The frequency of A*24 with histidine at codon 70 (A*2402/03/10), based on main anchor binding site specificity analysis in DSS and DHF patients, was significantly higher than that in the population background groups (HCMC 02-03 DSS: OR = 1.89, P = 0.008, DHF: OR = 1.75, P = 0.033; VL 02-03 DSS: OR = 1.70, P = 0.03, DHF: OR = 1.46, P = 0.38; VL 04-05 DSS: OR = 2.09, P = 0.0075, DHF: OR = 2.02, P = 0.038). In HLA class II, the HLA-DRB1*0901 frequency was significantly decreased in secondary infection of DSS in VL 04-05 (OR = 0.35, P = 0.0025, Pc = 0.03). Moreover, the frequency of HLA-DRB1*0901 in particular was significantly decreased in DSS when compared with DHF in DEN-2 infection (P = 0.02).
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 87 89 <span type="species:ncbi:12637">DV</span>
###xml 235 237 <span type="species:ncbi:12637">DV</span>
This study improves our understanding of the risk of HLA-class I for severe outcome of DV infection in the light of peptide anchor binding site and provides novel evidence that HLA-class II may control disease severity (DHF to DSS) in DV infection.
###end p 7
###begin title 8
Author Summary
###end title 8
###begin p 9
###xml 113 125 <span type="species:ncbi:12637">dengue virus</span>
###xml 377 385 <span type="species:ncbi:9606">children</span>
###xml 613 618 <span type="species:ncbi:9606">Human</span>
###xml 868 876 <span type="species:ncbi:9606">children</span>
###xml 968 975 <span type="species:ncbi:9606">persons</span>
###xml 1110 1117 <span type="species:ncbi:9606">persons</span>
###xml 1270 1272 <span type="species:ncbi:12637">DV</span>
Dengue has become one of the most common viral diseases transmitted by infected mosquitoes (with any of the four dengue virus serotypes: DEN-1, -2, -3, or -4). It may present as asymptomatic or illness, ranging from mild to severe disease. Recently, the severe forms, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), have become the leading cause of death among children in Southern Vietnam. The pathogenesis of DHF/DSS, however, is not yet completely understood. The immune response, virus virulence, and host genetic background are considered to be risk factors contributing to disease severity. Human leucocyte antigens (HLA) expressed on the cell surface function as antigen presenting molecules and those polymorphism can change individuals' immune response. We investigated the HLA-A, -B (class I), and -DRB1 (class II) polymorphism in Vietnamese children with different severity (DHF/DSS) by a hospital-based case-control study. The study showed persons carrying HLA-A*2402/03/10 are about 2 times more likely to have severe dengue infection than others. On the other hand, HLA-DRB1*0901 persons are less likely to develop DSS with DEN-2 virus infection. These results clearly demonstrated that HLA controlled the susceptibility to severe forms of DV infection.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 104 107 104 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Wagenaar1">[1]</xref>
###xml 181 184 181 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Chaturvedi1">[2]</xref>
###xml 398 401 398 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-World1">[3]</xref>
###xml 506 509 506 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Chaturvedi2">[4]</xref>
###xml 619 622 619 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-World2">[5]</xref>
###xml 733 736 733 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Nguyen1">[6]</xref>
###xml 0 12 <span type="species:ncbi:12637">Dengue virus</span>
###xml 14 16 <span type="species:ncbi:12637">DV</span>
###xml 133 139 <span type="species:ncbi:9606">people</span>
###xml 168 170 <span type="species:ncbi:12637">DV</span>
###xml 226 228 <span type="species:ncbi:12637">DV</span>
###xml 403 411 <span type="species:ncbi:9606">Children</span>
###xml 646 648 <span type="species:ncbi:12637">DV</span>
###xml 704 712 <span type="species:ncbi:9606">children</span>
Dengue virus (DV) infection has become one of the most important mosquito-borne diseases in the tropics [1]. An estimated 50 million people worldwide are infected with DV each year [2]. There are two principal severe forms of DV infection, namely dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Other severe forms such as encephalitis and spastic tetraparesis occur less frequently [3]. Children younger than 15 years of age account for 90% of the severe cases in Southeast Asian countries [4] where the DHF/DSS incidence has increased about 5 fold more rapidly since 1980 than in the previous 30 years [5]. These severe forms of DV infection have become the leading cause of death among children in Southern Vietnam [6].
###end p 11
###begin p 12
###xml 524 527 524 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-World1">[3]</xref>
###xml 1105 1108 1105 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-World3">[7]</xref>
###xml 39 41 <span type="species:ncbi:12637">DV</span>
###xml 1060 1068 <span type="species:ncbi:9606">patients</span>
Infection by any of the 4 serotypes of DV, DEN-1, -2, -3, and -4, may result in no symptoms, dengue fever (DF, without any serious complications), DHF or DSS. DF is characterized by high fever; severe headache; retro-orbital, muscle, bone or joint pains; and rash. DHF is characterized by the development of plasma leakage near the time of defervescence, thrombocytopenia, coagulation abnormalities, and hemorrhage. Hypotension with massive hemorrhage and plasma leakage characterize the most serious form of DHF called DSS [3]. DHF in this study corresponds to a milder form of DHF that WHO criteria define as grade I and II, and DSS to a grade III and IV DHF. The four criteria in the WHO case definition for DHF (fever, hemorrhage, thrombocytopenia and plasma leakage) were claimed not so practical because serious cases sometimes lack one or more of them, particularly hemorrhage and thrombocytopenia. Instead the Integrated Management of Childhood Illness (IMCI) has recently proposed the use of the terms "dengue" and "severe dengue" for the symptomatic patients with no emphasis on those two signs [7]
###end p 12
###begin p 13
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Halstead1">[8]</xref>
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Halstead1">[8]</xref>
###xml 222 225 222 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Halstead1">[8]</xref>
###xml 268 271 268 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Chaturvedi2">[4]</xref>
###xml 304 307 304 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Suharti1">[9]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Pang1">[10]</xref>
###xml 335 338 335 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Chaturvedi2">[4]</xref>
###xml 626 629 626 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Halstead1">[8]</xref>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-White1">[11]</xref>
###xml 823 826 823 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Wagenaar1">[1]</xref>
The pathogenesis of DHF/DSS is not yet completely understood. Host immunity has been extensively analyzed, including studies of antibody-dependent enhancement (ADE) [8], complement activation [8], anti-platelet antibodies [8], suppressed Th1/predominant Th2 functions [4] and the production of cytokines [9],[10] and cytotoxic factors [4]. Virus factor has also been studied. DEN-2 viral strains were associated with DHF/DSS in Thailand and Vietnam; DEN-3 strains have been predominant in the DHF/DSS in Sri Lanka, Indonesia and India; while in Latin America, DEN-2,-3,-4 have all been commonly associated with severe disease [8],[11]. In addition to those, still unidentified variations in immune response, virus virulence, and host genetic background are considered to be risk factors contributing to disease development [1].
###end p 13
###begin p 14
###xml 281 285 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Loke1">[12]</xref>
###xml 686 690 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Sakuntabhai1">[13]</xref>
Several genetic factors potentially influencing the severity of dengue infection, such as vitamin D receptor (VDR), Fcgamma receptor II (FcgammaRII), interleukin-4 (IL-4), interleukin-1 receptor antagonist (IL-1RA), and mannose-binding lectin (MBL) were investigated in Vietnamese [12]. Among them, the T allele at position 352 of the VDR gene was associated with resistance to DSS as well as homozygotes for the arginine variant at position 131 of the FcgammaRII gene were shown to be protective against DSS. Additionally, the G allele at position -336 of DC-SIGN (dendritic cell-specific ICAM-3 grabbing nonintegrin) was reported to be protective against DF among the Thai population [13].
###end p 14
###begin p 15
###xml 40 52 40 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flaviviridae</italic>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-King1">[14]</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-King1">[14]</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Spaulding1">[15]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Zivna1">[16]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Loke2">[17]</xref>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Stephens1">[18]</xref>
###xml 0 12 <span type="species:ncbi:12637">Dengue virus</span>
###xml 219 221 <span type="species:ncbi:12637">DV</span>
###xml 295 297 <span type="species:ncbi:12637">DV</span>
###xml 421 423 <span type="species:ncbi:12637">DV</span>
###xml 636 638 <span type="species:ncbi:12637">DV</span>
Dengue virus, like other members of the Flaviviridae family, increases the expression of HLA class I and II molecules on infected cells [14]. HLA-controlled immune response may be responsible for the immunopathology of DV infection [14]. The host HLA allele profile influenced the reactivity of DV-specific T cells [15],[16] however, there have been only a few informative studies on HLA association with the severity of DV infection [17],[18]. In the present study, we investigated the HLA-A, HLA-B, and HLA-DRB1 polymorphisms in the Vietnamese population and the association of HLA alleles with two different clinical forms of severe DV infection during the years 2002-2005.
###end p 15
###begin title 16
Materials and Methods
###end title 16
###begin title 17
Study subjects
###end title 17
###begin p 18
###xml 46 54 <span type="species:ncbi:9606">Children</span>
###xml 232 240 <span type="species:ncbi:9606">children</span>
###xml 548 550 <span type="species:ncbi:12637">DV</span>
###xml 568 576 <span type="species:ncbi:9606">patients</span>
###xml 674 682 <span type="species:ncbi:9606">patients</span>
The study was performed at two hospitals, the Children's Hospital No. 2 in Ho Chi Minh City (HCMC) and the Center for Preventive Medicine in the Vinh Long Province (VL) of the Mekong Delta. The enrolment was consecutive sequence of children hospitalized at each hospital. The inclusion criteria at the entry point in the hospital were age 6 months to 15 years old, Kinh race, and unrelatedness. The subjects enrolled initially were 325, 356 and 403 in HCMC 2002-2003 (HCMC 02-03), VL 2002-2003 (VL 02-03) and VL 2004-2005 (VL 04-05), respectively. DV infection of the patients was diagnosed by clinical symptoms and history at the admission time. After hospitalization, the patients were diagnosed by the well established serology as described below.
###end p 18
###begin p 19
###xml 28 31 28 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-World1">[3]</xref>
###xml 93 100 <span type="species:ncbi:9606">patient</span>
WHO classification criteria [3] was applied after a review of case report form (CRF) of each patient. The DHF classification required fever or a history of acute fever, bleeding manifestation, and signs of plasma leakage which include hemoconcentration, ascites, or pleural effusion with evidence of thrombocytopenia. Hemoconcentration (more than 20% increase in Hct) was evaluated by estimating the percent increase in the Hct by comparing two values recorded at 2 different timings: the maximum value in defervescence day and the value before discharge. The ascites, or pleural effusion were detected by echography or X-ray. The DSS classification required DHF manifestation plus evidence of clinical hypovolemic shock (tachycardia and narrow pulse pressure (<20 mmHg))
###end p 19
###begin p 20
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Jos1">[19]</xref>
###xml 500 503 500 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-World3">[7]</xref>
###xml 217 225 <span type="species:ncbi:9606">patients</span>
It was previously reported that the sensitivity of WHO criteria for DSS in Vietnam was 82%, mainly due to the lack of evidence for thrombocytopenia [19]. Therefore, we basically followed the WHO criteria but included patients lacking the significant reduction of platelet count, which accounted for no more than 11% of all DHF/DSS cases. Our classification met the requirement of the simplified classification system of IMCI, which is based on plasma leakage as a hallmark of severe dengue (DHF/DSS) [7].
###end p 20
###begin p 21
###xml 25 33 <span type="species:ncbi:9606">children</span>
###xml 115 127 <span type="species:ncbi:12637">dengue virus</span>
###xml 327 329 <span type="species:ncbi:12637">DV</span>
###xml 362 364 <span type="species:ncbi:12637">DV</span>
Healthy unrelated school children living in HCMC and VL (250 and 200 subjects respectively) who had no symptoms of dengue virus infection were collected as a background population control group for the genetic study. In these control groups, 13 cases (5.2%) in HCMC and 16 cases (8.0%) in VL were seropositive for IgM ELISA to DV, indicating recent asymptomatic DV infection.
###end p 21
###begin p 22
This study was approved by the institutional ethical review committees of the Institute of Tropical Medicine, Nagasaki University, and the Pasteur Institute in Ho Chi Minh City. Informed consent was obtained from the parents or legal guardians of the subjects upon enrollment.
###end p 22
###begin title 23
Sample collection and serological diagnosis
###end title 23
###begin p 24
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Innis1">[20]</xref>
###xml 799 802 797 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-World1">[3]</xref>
###xml 886 890 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Innis1">[20]</xref>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 228 230 <span type="species:ncbi:12637">DV</span>
###xml 433 435 <span type="species:ncbi:12637">DV</span>
###xml 525 527 <span type="species:ncbi:12637">DV</span>
###xml 542 569 <span type="species:ncbi:11072">Japanese encephalitis virus</span>
###xml 857 859 <span type="species:ncbi:12637">DV</span>
Blood samples were collected from patients with suspected dengue infection at the time of enrolment to the study and in the convalescent phase prior to discharge from the hospital. Plasma samples were used for titration of anti-DV IgM and IgG antibodies, virus isolation, and RT-PCR for determination of viral serotype; buffy coat samples were used to extract genomic DNA by using the QIAamp DNA blood kit (Qiagen, Hilden, Germany). DV infection was defined by previously established serologic criteria for IgM/IgG ELISAs to DV (DEN 1-4) and Japanese encephalitis virus (kit of Pasteur Institute HCMC) in paired sera, collected at least three days interval [20]. IgM and IgG ELISAs were considered positive if the ratio of optical density (OD) of test sera to OD of negative control sera was >/=2.3 [3]. The cases were diagnosed as secondary infection when DV IgM-to-IgG ratio was <1.8 [20].
###end p 24
###begin title 25
###xml 0 12 <span type="species:ncbi:12637">Dengue virus</span>
Dengue virus serotyping
###end title 25
###begin p 26
###xml 49 65 49 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aedes albopictus</italic>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Gubler1">[21]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Gubler1">[21]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Lanciotti1">[22]</xref>
###xml 881 885 881 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Lanciotti1">[22]</xref>
###xml 49 65 <span type="species:ncbi:7160">Aedes albopictus</span>
###xml 110 122 <span type="species:ncbi:12637">dengue virus</span>
###xml 460 462 <span type="species:ncbi:12637">DV</span>
###xml 538 540 <span type="species:ncbi:12637">DV</span>
###xml 822 824 <span type="species:ncbi:12637">DV</span>
Acute plasma samples were inoculated into C6/36 (Aedes albopictus) cells, the virus was then obtained and the dengue virus serotype was identified using the direct or indirect fluorescent antibody technique monoclonal antibodies supplied by the Centers for Disease Control and Prevention (Fort Collins, CO, USA) [21]. Viral RNA was also extracted from the same acute plasma samples with the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany) for detection of DV and confirmation of its serotype as described [21]. Briefly, cDNA from the DV genome RNA was amplified with the Ready-to-go RT-PCR test kit (Amersham, MA, USA) using consensus primer set (D1 and D2) [22]. Then, the serotype was determined by semi-nested PCR to amplify serotype-specific fragments from the regions encoding the capsid and membrane proteins of DV using the specific primer sets (TS1, TS2, TS3, and TS4) [22].
###end p 26
###begin title 27
HLA typing
###end title 27
###begin p 28
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Charron1">[23]</xref>
HLA-A, -B and -DRB1 were typed by using LABType SSO class I A and B and class II DRB1 locus kits (One Lambda, CA, USA) and the Luminex LX 100 IS system (Hitachi, Japan). IS 2.3 typing software (Luminex Corporation, TX, USA) was used to determine the genotype. The presence of alleles of interest were confirmed by PCR with sequence-specific primers (PCR-SSP) [23] (HLA-A*24) and sequencing-based typing (HLA-DRB1*0901) [according to the standard protocol 10-B of the 13th International Histoconpatibility Workshop ()]. HLA-A, HLA-B, and HLA-DRB1 genotype distributions were checked with Hardy-Weinberg equilibrium.
###end p 28
###begin title 29
Statistical analysis
###end title 29
###begin p 30
###xml 582 589 <span type="species:ncbi:9606">patient</span>
The frequencies of individuals carrying particular alleles (phenotype frequencies) were compared between categories of the case group (DHF or DSS) and the population background group. The difference in frequency was evaluated by the odds ratio (OR) with Fisher exact 95% confidence intervals (95% CI), and Exact Fisher two sided P using StatsDirect statistical software, version 2.6.4. The locus-wise correction of the P value (Pc) for multiple tests was made by multiplying the P value by the number of the major alleles whose phenotype frequencies were more than 5% in either the patient or population background group. The correction factors (CF) were 8 for HLA-A, 13 for HLA-B and 12 for HLA-DRB1. Difference yielding Pc values less than 0.05 was considered statistically significant.
###end p 30
###begin title 31
Results/Discussion
###end title 31
###begin title 32
###xml 25 33 <span type="species:ncbi:9606">patients</span>
Clinical features of the patients
###end title 32
###begin p 33
###xml 69 76 69 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t001">Table 1</xref>
###xml 325 332 325 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t001">Table 1</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Butt1">[24]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Faridi1">[25]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-DazQuijano1">[26]</xref>
###xml 527 533 527 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 614 618 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Pham1">[27]</xref>
###xml 192 200 <span type="species:ncbi:9606">patients</span>
###xml 391 399 <span type="species:ncbi:9606">patients</span>
###xml 439 447 <span type="species:ncbi:9606">patients</span>
###xml 605 613 <span type="species:ncbi:9606">children</span>
Demographic and clinical features of the study subjects are shown in Table 1. An important clinical findings in this study was hepatomegaly which was clearly more prevalent in DSS than in DHF patients (in HCMC 02-03: 90.8% vs. 47.9%, in VL 02-03: 98.8% vs. 88.6%, and in VL 04-05: 93.8% vs. 78.0%, ORs above 4, footnote b of Table 1). There was substantial evidence of hepatomegaly in Asian patients [24],[25] as well as in South American patients [26] with DHF/DSS. Our results therefore agree with the previous study by Pham et al. which propose hepatomegaly as one of the clinical predictors of DSS in children [27].
###end p 33
###begin title 34
Study subjects
###end title 34
###begin p 35
DHF: dengue hemorrhagic fever, DSS: dengue shock syndrome, SD: standard deviation, nd: not done, P: Fisher's exact test, Hct: hematocrit.
###end p 35
###begin p 36
###xml 15 23 <span type="species:ncbi:9606">patients</span>
Male among DSS patients in VL04-05 vs. VL controls: P = 0.008
###end p 36
###begin p 37
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Hepatomegaly among DSS patients vs. DHF patients, in HCMC 02-03: OR = 10.74, P<0.0001, in VL 02-03: OR = 10.84, P = 0.008, in VL 04-05:OR = 4.24, P = 0.005
###end p 37
###begin p 38
Secondary infection in DSS VL04-05 vs. HCMC 02-03: P<0.0001, VL04-05 vs. VL02-03: P<0.0001 and in DHF VL04-05 vs. HCMC 02-03: P<0.0001, VL04-05 vs. VL02-03: P = 0.0001
###end p 38
###begin p 39
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Chao1">[28]</xref>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Sriprom1">[29]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Sriprom1">[29]</xref>
###xml 617 624 617 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t001">Table 1</xref>
###xml 89 91 <span type="species:ncbi:12637">DV</span>
###xml 246 254 <span type="species:ncbi:9606">patients</span>
###xml 438 446 <span type="species:ncbi:9606">patients</span>
Another point of note was concerning the issue of significance of secondary infection of DV in the pathogenesis of severe cases. Although secondary infection has been reported to confer most of the risk of disease severity, it is also known that patients without evidence of secondary infection substantially contribute to severe cases in Taiwan [28] and Thailand [29]. Our study is similar to that study in Thailand 2003 [29], where the patients with high IgM/IgG ratio consist of nearly 60% of DSS and 40% of DHF. The data still support the notion of disease risk associated with secondary infection (footnote c of Table 1).
###end p 39
###begin p 40
###xml 262 268 262 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Halstead2">[30]</xref>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 103 105 <span type="species:ncbi:12637">DV</span>
###xml 286 293 <span type="species:ncbi:9606">infants</span>
It is worth to mention that four percents of our patients were under 1 year of age and all had primary DV infection. The presence of non neutralizing or low level of neutralizing maternal antibodies may play a role in the development of severe disease. Halstead et al. pointed out that infants are a high risk group for DHF/DSS, and need to be studied to further understand primary dengue infection [30].
###end p 40
###begin title 41
###xml 0 2 <span type="species:ncbi:12637">DV</span>
DV serotypes and disease severity
###end title 41
###begin p 42
###xml 154 161 154 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t002">Table 2</xref>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Innis1">[20]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Islam1">[31]</xref>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 163 165 <span type="species:ncbi:12637">DV</span>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
###xml 360 362 <span type="species:ncbi:12637">DV</span>
Virus serotype was tested on 388 patients whose blood samples collected within five days after the onset of symptoms, mostly on days 4 and 5. As shown in Table 2, DV was identified in 87 DHF/DSS patients, which gave a detection rate of 22.4%. This was far lower than many other studies but consistent with a previous observation that the sensitivity to detect DV is dulled in the present of neutralizing antibody [20]. Similar low detection rate was reported in Bangladesh study in 2002 [31], where virus serotype could only be identified in 8% of samples.
###end p 42
###begin title 43
###xml 0 12 <span type="species:ncbi:12637">Dengue virus</span>
Dengue virus serotypes and disease severity (2002-05)
###end title 43
###begin p 44
DHF: dengue hemorrhagic fever, DSS: dengue shock syndrome
###end p 44
###begin p 45
OR: Odds ratio, 95% CI: Fisher exact 95% confidence intervals, P: Fisher's exact test
###end p 45
###begin p 46
###xml 203 210 203 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t002">Table 2</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Vaughn1">[32]</xref>
###xml 313 321 <span type="species:ncbi:9606">patients</span>
DEN-2 constituted the majority of the total isolates, 50 (57.5%) followed by 16 DEN-1 (18.4%), 13 DEN-3 (14.9%) and 8 DEN-4 (9.2%). The correlation between DEN-2 infection and the severe clinical forms (Table 2) provided additional proof for higher virulence of this serotype because previous study reported that patients with DEN-2 had a larger pleural effusion index than those infected by other virus serotypes [32].
###end p 46
###begin title 47
Phenotype frequencies of HLA-A, HLA-B and HLA-DRB1
###end title 47
###begin p 48
###xml 218 225 218 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t003">Table 3</xref>
###xml 230 238 230 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000304.s003">Table S1</xref>
###xml 568 576 568 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000304.s003">Table S1</xref>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Loke2">[17]</xref>
###xml 167 174 <span type="species:ncbi:9606">patient</span>
We identified 16 HLA-A alleles, 47 HLA-B alleles and 36 HLA-DRB1 alleles in the study subjects. Major alleles (phenotype frequencies having more than 5% in either the patient or healthy background groups) are shown in Table 3 and Table S1, accounted for about 80-90% of the total phenotypes. We analyzed only these major alleles for the evaluation of the risk of disease severity because rare alleles would have little impact on population risk. There were no significant difference in phenotype frequencies of the major alleles in the 2 population background groups (Table S1), and these data were compatible with data from a previous study [17] on the same Kinh ethnic in Southern Vietnam.
###end p 48
###begin title 49
Major alleles of HLA-A, -B, -DRB1 in Vietnamese
###end title 49
###begin title 50
HLA-A*24 was positively associated with DSS or DHF
###end title 50
###begin p 51
###xml 12 19 12 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t004">Table 4</xref>
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t005">5</xref>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
As shown in Table 4 and 5, HLA-A*24 increased in frequency among DHF and DSS patients when compared with the control in all 3 sample groups, HCMC 02-03 (DSS: OR = 1.62, P = 0.04, Pc = 0.3; DHF: OR = 1.35, P = 0.26), VL 02-03 (DSS: OR = 1.51, P = 0.08; DHF: OR = 1.34, P = 0.4), and VL 04-05 (DSS: OR = 1.80, P = 0.029, Pc = 0.2; DHF: OR = 2.71, P = 0.0019, Pc = 0.02).
###end p 51
###begin title 52
Phenotype frequencies of HLA-A*24 and HLA-DRB1*0901 in primary and secondary infection and population background groups
###end title 52
###begin p 53
DHF: dengue hemorrhagic fever, DSS: dengue shock syndrome
###end p 53
###begin title 54
Association of HLA-A*24, -DRB1*0901 allele with severe forms
###end title 54
###begin p 55
DHF: dengue hemorrhagic fever, DSS: dengue shock syndrome, OR: Odds ratio, 95% CI: Fisher exact 95% confidence intervals, P: Fisher's exact test, Pc: corrected P.
###end p 55
###begin p 56
###xml 96 99 96 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Wagenaar1">[1]</xref>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Stephens1">[18]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-ParadoaPerez1">[33]</xref>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Loke2">[17]</xref>
###xml 548 551 548 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Chaturvedi1">[2]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-BeatrizSierra1">[34]</xref>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 337 345 <span type="species:ncbi:9606">patients</span>
Certain alleles of the HLA-class I genes were previously found to be associated with DHF or DSS [1]. In a study of Thai patients, Stephens et al. found that HLA- A*0207 and HLA-B*51 were susceptible to both DHF and DSS [18]. It was also reported that HLA-A*29 and A*33 were protective against DHF and DSS in Cuban [33] and in Vietnamese patients, respectively [17]. The inconsistency of these HLA associations may be the result of the differences in ethnicity, geographic location or the diversity of the predominant virus during the study periods [2],[34].
###end p 56
###begin p 57
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Loke2">[17]</xref>
The results of HLA class I association from the present study reproduced a previous Vietnamese study (309 cases and 251 controls) by Loke et al. in which HLA-A*24 association with DHF and DSS was found, with OR 1.54 and P value 0.021 [17]. Considering such reproducibility in different study periods, within the same ethnic group and in the same region, give us the confidence to assign an association of HLA-A*24 and DHF, DSS even though our P value just reached the significant level before Bonferoni correction.
###end p 57
###begin title 58
HLA-A*24 with Histidine at codon 70 was positively associated with DSS and DHF
###end title 58
###begin p 59
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Sidney1">[35]</xref>
###xml 320 327 320 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t006">Table 6</xref>
###xml 766 773 766 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t007">Table 7</xref>
###xml 905 912 905 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t006">Table 6</xref>
###xml 982 986 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Umapathy1">[36]</xref>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
###xml 972 975 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
It is known that HLA-A*24 alleles fall into at least two subtypes by the difference at codon 70 of alpha 1 domain, which together with codons 9, 45, 63, 66 and 67 composes peptide binding pocket B for P2 anchor position [35]. In the present study, there were 4 different A*24 alleles, A*2402, A*2403, A*2407 and A*2410 (Table 6). A*2407 is different from the others at codon 70 where histidine (CAC) is changed to glutamine (CAG). The frequencies of A*24 with histidine at codon 70 in DSS and DHF patients were significantly higher than that in the population background groups (HCMC 02-03 DSS: OR = 1.89, P = 0.008, DHF: OR = 1.75, P = 0.03; VL 02-03 DSS: OR = 1.70, P = 0.03, DHF OR = 1.46, P = 0.38; VL 04-05 DSS: OR = 2.09, P = 0.0075, DHF OR = 2.02, P = 0.038, Table 7). On the other hand, A*24 with glutamine at codon 70, A*2407 in our samples, did not show any significant difference in frequency (Table 6). Similar behavior of this allele was documented in Indian HIV study [36].
###end p 59
###begin title 60
Phenotype frequencies of HLA-A*24 subgroups
###end title 60
###begin p 61
DHF: dengue hemorrhagic fever, DSS: dengue shock syndrome
###end p 61
###begin title 62
###xml 71 73 <span type="species:ncbi:12637">DV</span>
Association of HLA-A*24 with histidine at codon 70 and severe forms of DV infection
###end title 62
###begin p 63
###xml 199 200 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
DHF: dengue hemorrhagic fever, DSS: dengue shock syndrome, OR: Odds ratio, 95% CI: Fisher exact 95% confidence intervals, P: Fisher's exact test. This analysis was perform after the confirmation of A*24 association, so that the correction of P value did not apply.
###end p 63
###begin p 64
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Mathew1">[37]</xref>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Loke2">[17]</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Simmons1">[38]</xref>
The association of HLA-A*24 in the VL 04-05 samples was stronger than in VL 02-03 and HCMC 02-03, possibly due to higher secondary infection rate in the VL 04-05 samples. Memory T cells might be important in the A*24 associated pathogenesis of DHF/DSS. HLA-A*24 is reported to be one of the potential restricting alleles for NS3 dengue viral protein and CTLs recognizing NS3 peptides coupled with HLA-A*24 were cross-reactive between serotypes because NS3 is highly conserved [37]. Two previous Vietnamese studies reported an identification of the DEN-2 NS3 556-564 peptide that was restricted by HLA-A*24 [17],[38], but further study is needed to clarify the role of A*24-restricted CD8 T-cells in the pathogenesis of DHF/DSS.
###end p 64
###begin title 65
HLA-DRB1*0901 was negatively associated with DSS
###end title 65
###begin p 66
###xml 12 19 12 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t004">Table 4</xref>
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t005">5</xref>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
As shown in Table 4 and 5, the HLA-DRB1*0901 allele significantly decreased in frequency in DSS patients in VL 04-05 (OR = 0.37, P = 0.0018, Pc = 0.02) when compared to the control, mainly in secondary infection (OR = 0.35, P = 0.0025, Pc = 0.03), not in primary infection. This trend was also observed in the other 2 groups of samples but did not reach statistical significance (VL 02-03: OR 0.51, P = 0.026, Pc = 0.3; HCMC 02-03: OR = 0.89, P = 0.77).
###end p 66
###begin p 67
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Maureen1">[39]</xref>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-BeatrizSierra1">[34]</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-LaFleur1">[40]</xref>
###xml 798 802 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Charron2">[41]</xref>
###xml 1386 1390 1386 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Burdett1">[42]</xref>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 123 126 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 129 146 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 148 151 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 158 175 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 177 180 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 191 203 <span type="species:ncbi:12637">dengue virus</span>
###xml 863 871 <span type="species:ncbi:9606">patients</span>
Certain HLA class II alleles have been reported to confer a protective effect in infections of human immunodefiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) [39]. In dengue virus infection, protective DRB1*07 and DRB1*04 alleles were recently reported. DRB1*07 was protective against DF, DHF and DSS and DRB1*04 was protective against secondary DF in Cuban population [34], DHF or DSS in Mexican population [40]. Possibly there is a common primary associated gene closely located to DRB1 locus, such as HLA-DQB1 and HLA-DRB4, for those alleles (DRB1*07 and DRB1*04) and Vietnamese DRB1*0901. One of the most frequent haplotypes among Oriental populations (including Kinh ethnic) is DRB1*0901-DQB1*030302. DQB1*030302 is also reported to be in disequilibrium with DRB1*0701 [41], however there was no reduced frequency of DRB1*0701 in DSS patients compared to controls in our data. Furthermore, haplotypes found in South America are DRB1*0701-DQB1*0201 and HLA-DRB1*0403-DQB1*0302, not DQB1*030302, which suggests that the association of these protective alleles could not be elucidated by a common DQB1 allele. The possibility of primary disease-protective association with DRB4*01 (encoding DR53 sero-specificity) remains to be examined because of DRB4*01 haplotypic association with DRB1*07, *04 and *0901 was found in all populations which have been studied [42], although neither DRB1*07 or DRB1*04 exhibited difference in frequency in our samples.
###end p 67
###begin title 68
Protective effect of HLA-DRB1*0901 against DSS development from DHF was evident when having DEN-2 infection
###end title 68
###begin p 69
###xml 208 215 208 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t008">Table 8</xref>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
###xml 316 324 <span type="species:ncbi:9606">patients</span>
To see the effect of virus serotype on the HLA susceptibility, we analyzed the HLA alleles in the DEN-2-positive patients and those that were positive for DEN-1, DEN-3, or DEN-4 (DEN-2-negative). As shown in Table 8, HLA-DRB1*0901 frequency was significantly decreased in DSS compared with DHF among DEN-2- positive patients (OR = 0.13, P = 0.02). The effect of DRB1*0901 appeared to be DEN-2 specific because DEN-2-negative population did not show significant difference, although this may be due to the small sample size as Breslow-Day statistic for the uniformity of odds ratio did not reach significant level (P = 0.14).
###end p 69
###begin title 70
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Phenotype frequency of HLA- DRB1*0901 allele in DHF or DSS patients with DEN-2 or other serotypes
###end title 70
###begin p 71
DHF: dengue hemorrhagic fever, DSS: dengue shock syndrome,
###end p 71
###begin p 72
###xml 60 67 60 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000304-t002">Table 2</xref>
DEN-2 (-): consisted of DEN-1, DEN-3, and DEN-4 as shown in Table 2.
###end p 72
###begin p 73
OR: Odds ratio, 95%CI: Fisher exact 95% confidence intervals, P: Fisher's exact test.
###end p 73
###begin p 74
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Tokushige1">[43]</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Aikawa1">[44]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000304-Chaturvedi3">[45]</xref>
###xml 84 87 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
###xml 331 339 <span type="species:ncbi:9606">patients</span>
###xml 588 596 <span type="species:ncbi:9606">patients</span>
###xml 933 941 <span type="species:ncbi:9606">patients</span>
The HLA-DRB1*0901 allele has also been reported at higher frequency in noncirrhotic HCV patients than in patients with cirrhosis [43],[44], suggesting protective effect of this allele against tissue destruction and disease progression. Here, when we focus on DEN-2 infection, a higher frequency of HLA-DRB1*0901 in DHF than in DSS patients was found. The protective effect of this allele against DSS development from DHF could be considered as a new finding in dengue infection. It is generally believed that DSS is preventable by intense clinical management, in fact a certain number of patients, however fall to shock in spite of the early efforts of physicians. Although the pathogenesis of DHF/DSS is still unclear, clinical studies have suggested that the host immune response shifted to Th2 dominant in most DSS cases [45]. Because HLA class II polymorphism can direct the antigen-specific T-cell response, it is probable that patients with HLA-DRB1*0901 may be prevented from the shift toward Th2 dominance. Further studies are needed to clarify this point.
###end p 74
###begin p 75
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 426 428 <span type="species:ncbi:12637">DV</span>
###xml 576 578 <span type="species:ncbi:12637">DV</span>
In conclusion, our study confirmed the previous reported HLA association between HLA-A*24 and DHF or DSS and moreover showed that A*24 with Histidine at codon 70 to be susceptible to DSS and DHF, and HLA-DRB1*0901 to be protective against the development of DSS, particularly in patients with DEN-2 infection. This study represents another attempt to improve our understanding of the risk of HLA-class I for severe outcome of DV infection in the light of peptide anchor binding site and provides a novel evidence that HLA-class II may control disease severity (DHF to DSS) in DV infection.
###end p 75
###begin title 76
Supporting Information
###end title 76
###begin p 77
Translation of the Abstract into Japanese by Kenji Hirayama
###end p 77
###begin p 78
(0.09 MB PDF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
Translation of the Abstract into Vietnamese by Nguyen Thi Phuong Lan
###end p 80
###begin p 81
(0.04 MB DOC)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
Phenotype frequencies of HLA-A, HLA-B and HLA-DRB1 alleles
###end p 83
###begin p 84
(0.17 MB DOC)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
The authors express their appreciation to the Drs. Nguyen Thi Kim Tien, Duane J. Gubler, and Anavaj Sakuntabhai for continuous support and helpful discussion; and to all the members of Laboratory of Arbovirus, Pasteur Institute, Ho Chi Minh City, for their laboratory help.
###end p 86
###begin title 87
References
###end title 87
###begin article-title 88
###xml 22 34 <span type="species:ncbi:12637">dengue virus</span>
Genetic influences on dengue virus infections.
###end article-title 88
###begin article-title 89
Dengue and dengue haemorrhagic fever: implications of host genetics.
###end article-title 89
###begin article-title 90
Dengue hemorrhagic fever: diagnosis, treatment, prevention, and control.
###end article-title 90
###begin article-title 91
###xml 15 27 <span type="species:ncbi:12637">dengue virus</span>
Macrophage and dengue virus: Friend or foe?
###end article-title 91
###begin article-title 92
Prevention and control of dengue and dengue hemorrhagic fever: comprehensive guidelines. WHO Regional publication, SEARO No. 29.
###end article-title 92
###begin article-title 93
Annual report of National program for dengue control in Vietnam.
###end article-title 93
###begin article-title 94
Dengue, dengue haemorrhagic fever and dengue shock syndrome in the context of the integrated management of childhood illness.
###end article-title 94
###begin article-title 95
Dengue.
###end article-title 95
###begin article-title 96
Cytokine patterns during dengue shock syndrome.
###end article-title 96
###begin article-title 97
Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).
###end article-title 97
###begin article-title 98
###xml 26 38 <span type="species:ncbi:12637">dengue virus</span>
Variation in virulence of dengue virus.
###end article-title 98
###begin article-title 99
Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fc gamma receptor IIa genes.
###end article-title 99
###begin article-title 100
A variant in the CD209 promoter is associated with severity of dengue disease.
###end article-title 100
###begin article-title 101
Immune modulation by flaviviruses.
###end article-title 101
###begin article-title 102
###xml 12 18 <span type="species:ncbi:10090">murine</span>
###xml 54 66 <span type="species:ncbi:12637">Dengue virus</span>
Analysis of murine CD8+T-cell clones specific for the Dengue virus NS3 protein: flavivirus crossreactivity and influence of infecting serotype.
###end article-title 102
###begin article-title 103
T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity.
###end article-title 103
###begin article-title 104
Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?
###end article-title 104
###begin article-title 105
###xml 48 60 <span type="species:ncbi:12637">dengue virus</span>
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.
###end article-title 105
###begin article-title 106
Severe dengue: the need for new case definitions.
###end article-title 106
###begin article-title 107
###xml 88 109 <span type="species:ncbi:11072">Japanese encephalitis</span>
An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.
###end article-title 107
###begin article-title 108
Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses.
###end article-title 108
###begin article-title 109
Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.
###end article-title 109
###begin article-title 110
###xml 2 4 2 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
12th International Histocompatibility Workshop and Conference Proceedings: Genetic Diversity of HLA: Functional and Medical Implications.
###end article-title 110
###begin article-title 111
Haematological and Biochemical Indicators for the Early Diagnosis of Dengue Viral Infection.
###end article-title 111
###begin article-title 112
###xml 65 73 <span type="species:ncbi:9606">children</span>
Clinical and biochemical profile of dengue haemorrhagic fever in children in Delhi.
###end article-title 112
###begin article-title 113
###xml 32 44 <span type="species:ncbi:12637">dengue virus</span>
Early indicators of severity in dengue virus infection.
###end article-title 113
###begin article-title 114
###xml 51 59 <span type="species:ncbi:9606">Children</span>
Predictive factors of dengue shock syndrome at the Children hospital No.1, Ho Chi Minh City, Vietnam.
###end article-title 114
###begin article-title 115
1998 dengue hemorrhagic fever in Taiwan.
###end article-title 115
###begin article-title 116
Dengue hemorrhagic fever in Thailand, 1998-2003: Primary or secondary infection.
###end article-title 116
###begin article-title 117
###xml 28 35 <span type="species:ncbi:9606">Infants</span>
Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored.
###end article-title 117
###begin article-title 118
Molecular characterization and clinical evaluation of dengue outbreak in 2002 in Bangladesh.
###end article-title 118
###begin article-title 119
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
###end article-title 119
###begin article-title 120
Association of dengue hemorrhagic fever with the HLA system.
###end article-title 120
###begin article-title 121
###xml 157 169 <span type="species:ncbi:12637">dengue virus</span>
HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: Advantages of the Cuban population for HLA studies of dengue virus infection.
###end article-title 121
###begin article-title 122
HLA class I supertypes: a revised and updated classification.
###end article-title 122
###begin article-title 123
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Specific human leukocyte antigen alleles associated with HIV-1 infection in an Indian population.
###end article-title 123
###begin article-title 124
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 61 73 <span type="species:ncbi:12637">dengue virus</span>
Dominant recognition by human CD8-cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.
###end article-title 124
###begin article-title 125
###xml 26 38 <span type="species:ncbi:12637">dengue virus</span>
###xml 84 96 <span type="species:ncbi:12637">dengue virus</span>
Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections.
###end article-title 125
###begin article-title 126
Immunogenetics of viral infections.
###end article-title 126
###begin article-title 127
###xml 38 46 <span type="species:ncbi:9606">patients</span>
###xml 52 64 <span type="species:ncbi:12637">dengue virus</span>
HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever.
###end article-title 127
###begin article-title 128
12th International Histocompatibility Workshop and Conference Proceedings: Genetic Diversity of HLA: Functional and Medical Implications.
###end article-title 128
###begin article-title 129
DRB-DQB1 diversity in the analysis of 4727 donors tested by SBT.
###end article-title 129
###begin article-title 130
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 116 119 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Influence of TNF gene polymorphism and HLA-DRB1 haplotype in Japanese patients with chronic liver disease caused by HCV.
###end article-title 130
###begin article-title 131
HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatic C.
###end article-title 131
###begin article-title 132
Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis.
###end article-title 132
###begin p 133
The authors have declared that no competing interests exist.
###end p 133
###begin p 134
This work was supported in part by grants in aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) for the 21c COE program, for funding the overseas laboratory for the research network for infectious diseases and for the Tokutei research 2003-2005. N.T.P.L was given the Monbusho scholarship from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 134

